Delta rising, the new record highs and the data of 09.06.2021

The Philippines records a new record high with 22,415 cases today. In spite the over 20,000 recoveries, the active cases are up at almost 160,000. We now have a total of more than 2.1M cases and most likely will overtake Peru in 19th rank, any time this week.

With more than 73,000 tests done last September 4, 2021, we also record a new high in positivity rate at 28.8% or almost 1 in 3 to 4 patients tested, tested positive.

New deaths today were at 103, putting the case fatality ratio for outcomes is lower at 1.77%.

The NCR records also a record high of 6,335 new cases, with four other regions reporting quadruple digits. In fourth and fifth are Cagayan Valley and Davao Region. Again, it is important to emphasize that the erratic numbers and ranking in the different regions outside of NCR plus is secondary to the fact that the test results do not arrive at the same time. That lag, is something the Health Agency needs to fix. This lag is also due to the fewer laboratories outside of NCR plus. Results of patients from the other regions take a little longer to obtain.

On a provincial level – Cavite, Laguna and Bulacan continue to rank 1-3 for the 3rd consecutive day.

Twelve of 17 LGUs in NCR are in the top 20 cities with most cases with five cities from NCR in the top 5. Six LGUs from CALABARZON also make it to the top 20, with 3 from Cavite, 1 from Laguna, 1 from Batangas and 1 from Rizal.


Without a doubt, the Philippine Genome Center Biosurveillance report shows that the shift in the major variant of concern in the country. Based on 367 sequenced samples on September 3, 2021, 76% of the batch were delta variants.

The Delta Variant, first detected in October 2020 in India show mutations at L452R and T478K. Its major concern is in the higher transmissibility, but to date has no evidence of effect on causing a more severe presentation.

Because it has the ability to partially but significantly escape neutralizing antibodies targeting the NTD and RBD, and polyclonal antibodies elicited by previous SARS-CoV-2 infection or vaccination, this may affect the number of cases we are seeing in spite of the vaccine roll-out.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s